DXP ENTERPRISES INC (DXPE) Form 10-Q — Aug 6, 2026
DXP Enterprises reported Q2 2026 sales of $576.5 million, up 15.6% year over year, with diluted EPS of $1.76 versus $1.43 a year earlier. Organic sales grew 11.1%, while recent acquisitions contributed $49.8 million of the quarter's revenue. Growth was driven by the Innovative Pumping Solutions segment, up 52.6% to $142.7 million, as DXP deployed $135.6 million on four acquisitions in the first half of 2026 to expand its water and wastewater platform. The company also closed the acquisition of Mequipco Ltd., adding a Canadian water and wastewater presence, on August 1, 2026.
Key figures
- Eps
- 1.76
- Revenue
- 576461000
- Net Income
- 28708000
- Total Debt
- 842500000
- Revenue Yoy
- 15.6% (Q2 2026 vs Q2 2025)
- Total Assets
- 1769510000
- Cash Position
- 226618000
- Gross Margin Q2
- 31.8% vs 31.6% prior year
- New Abl Pricing
- Term SOFR/CORRA plus 1.25%-1.75%
- New Abl Maturity
- July 2, 2031
- Total Liquidity
- 374500000
- New Abl Accordion
- 50000000
- Six Month Revenue
- 1098119000
- Sp Rating Upgrade
- B to B+ on July 20, 2026
- Adjusted Ebitda Q2
- 70376000
- Ips Segment Sales Q2
- 142739000
- Shares Outstanding
- 15517148
- Six Month Net Income
- 48686000
- Ips Segment Growth Q2
- 52.6%
- Six Month Diluted Eps
- 2.98
- Organic Sales Growth Q2
- 11.1%
- Diluted Eps Prior Year Q2
- 1.43
- Free Cash Flow Six Months
- 56040000
- H1 Acquisition Goodwill
- 63802000
- Six Month Revenue Growth
- 12.6%
- Adjusted Ebitda Margin Q2
- 12.2%
- New Abl Facility Capacity
- 225000000
- Debt To Total Capitalization
- 60.9%
- H1 Acquisition Consideration
- 135559000
- Operating Cash Flow Six Months
- 61955000
- Buyback Remaining Authorization
- 68000000
- Contingent Consideration Balance
- 29826000
- Contingent Consideration Max Payable
- 33000000
Price after filing
Close on the filing date to close N calendar days later (from $170.98). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.